Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves c-reactive protein and is associated with postoperative arrhythmia

Circulation

Volumn 96, Issue 10, 1997, Pages 3542-3548

  Bruins, Peter ^a   Te Velthuis, Henk ^b   Yazdanbakhsh, Aria P ^a   Jansen, Piet G M ^a   Van Hardevelt, Fred W J ^a   De Beaumont, Eddy M F H ^a   Wildevuur, Charles R H ^a   Eijsman, León ^a   Trouwborst, Ad ^a   Hack, C Erik ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Arrhythmia; Complement; Extracorporeal circulation; Interleukins; Proteins

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; ENZYME ACTIVATION; EXTRACORPOREAL CIRCULATION; FEMALE; FEVER; HEART ARRHYTHMIA; HEART SURGERY; HUMAN; LEUKOCYTOSIS; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0030778802     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3542     Document Type: Article

References (33)

1. Downing SW, Edmunds L. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:1236-1243.
2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-857.
3. Kirklin JK. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg. 1991; 51:529-531.
4. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg. 1993;7:563-573.
5. Creswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56: 539-549.
6. Cox JL. A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg. 1993;56:405-409.
7. Chenoweth DE, Cooper SW, Hugh TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
8. Van Oeveren W, Kazatchkine MD, Descamps-Latscha B, Maillet F, Fischer E, Carpentier A, Wildevuur CRH. Deleterious effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985;89: 888-899.
9. Jansen PGM, te Velthuis H, Huybregts MAJM, Paulus R, Bulder ER, van der Spoel HI, Bezemer PD, Slaats EH, Eijsman L, Wildevuur CRH. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits. J Thorac Cardiovasc Surg. 1995;110: 829-834.
10. Kirklin JK, Chenoweth DE, Naftel DC, Blackstone EH, Kirklin JW, Bitran DD, Curd JG, Reves JG, Samuelson PN. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state. Ann Thorac Surg. 1986;41:193-199.
11. Butler J, Pillai R, Rocker GM, Westaby S, Parker D, Shale DJ. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg. 1993; 105:25-30.
12. Berger D, Bolke E, Huegel H, Seidelmann M, Hannekum A, Beger HG. New aspects concerning the regulation of the post-operative acute phase reaction during cardiac surgery. Clin Chim Acta. 1995; 239:121-130.
13. Vecht RJ, Nicolaides EP, Ikweuke JK, Liassides C, Cleary J, Cooper WB. Incidence and prevention of supraventricular tachyarrhythmias after coronary bypass surgery. Int J Cardiol. 1986; 13:125-134.
14. De Boer JP, Creasey AA, Chang A, Roem D, Eerenberg AJM, Hack CE, Taylor FB Jr. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern. Infect Immun. 1993;61:4293-4301.
15. Kaplan MH, Volanakis JE. Interaction of C-reactive protein complexes with the complement system. J Immunol. 1974;6:2135-2147.
16. Volanakis JE. Complement-induced solubilization of C-reactive protein-pneumococcal C-polysaccharide precipitates: evidence for covalent binding of complement proteins to C-reactive protein and to pneumococcal C-polysaccharide. J Immunol. 1982;128: 2745-2750.
17. Volanakis JE, Wirtz KWA. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 1979;281:155-157.
18. Hack CE, Wolbink GJ, Schalkwijk C, Speijer H, Hermens WT, van den Bosch H. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells. Immunol Today. 1997;18: 111-115.
19. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJM, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-CRP complexes. J Immunol. 1996;157:473-479.
20. 125I-CSa. J Immunol Methods. 1988;108:77-84.
21. Wolbink GJ, Bollen J, Baars JW, Berge ten RJM, Swaak AJG, Paardekooper J, Hack CE. Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway. J Immunol Methods. 1993;163:67-76.
22. Te Velthuis H, Jansen PGM, Hack CE, Eijsman L, Wildevuur CRH. Specific complement inhibition with heparin-coated extracorporeal circuits. Ann Thorac Surg. 1996;61:1153-1157.
23. Jansen PGM, te Velthuis H, Wildevuur WR, Huybregts MAJM, Bulder ER, van der Spoel HI, Sturk A, Eijsman L, Wildevuur CRH. Cardiopulmonary bypass with modified fluid gelatin and heparin-coated circuits. Br J Anaesth. 1996;76:13-19.
24. Hack CE, Paardekooper J, Smeenk RJT, Abbink JJ, Eerenberg AJM, Nuijens JH. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3: an analysis with monoclonal antibodies. J Immunol. 1988;141: 1602-1609.
25. Helle M, Boeije L, de Groot ER, de Vos A, Arden LA. Sensitive ELISA for interleukin 6: detection of IL-6 in biological fluids: synovial fluids and sera. J Imunnol Methods. 1991;138:47-56.
26. Mackiewicz A, Kushner I, Baumann H. Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. Boca Raton, Fla: CRC Press, Inc; 1993.
27. Redl H, Schlag G, Schiesser A, Davies J. Tumor necrosis factor is a mediator of phospholipase release during bacteremia in baboons. Am J Physiol. 1993;264:H2119-H2123.
28. Siegel J, Rent R, Gewurz H. Interactions of C-reactive protein with the complement system. J Exp Med. 1974;140:631-647.
29. Wu J, Corr PB. Influence of long chain acylcarnitines on the voltage-dependent calcium current in adult ventricular myocytes. Am J Physiol. 1992;263:H410-H417.
30. Del Balzo U, Polley MJ, Levi R. Cardiac anaphylaxis: complement activation as an amplification system. Circ Res. 1989;65:847-857.
31. Del Balzo UH, Levi R, Polley MJ. Cardiac dysfunction caused by purified human C3a anaphylatoxins. Proc Natl Acad Sci U S A. 1985;82:886-890.
32. Cox JL, Creswell LL, Schuessler RB, Rosenbloom M. Postoperative atrial arrhythmias. Ann Thorac Surg. 1994;58:914.
33. Ali IM, Murphy DA. Postoperative atrial arrhythmias. Ann Thorac Surg. 1994;58:913-914.